The HIV pandemic has threatened the health of men and women across the globe for over 30 years. Why, in this age of advanced medical technology, has the HIV virus has thwarted traditional methods of vaccination? The AIDS Vaccine 2012 conference, which just wrapped in Boston yesterday, focused on bringing new minds and ideas to this very question.
Some of the reasons include HIV’s ability to mutate, its prolonged period of “clinical latency,” and the social stigma—both real and perceived—around getting tested for the disease. But there is hope, not in the form of a vaccine, but in the recent FDA approval of the world’s first preventative HIV medication.
Truvada, already used in treatment of HIV patients, has been found (when paired with safe sex practices) to reduce the risk of HIV transmission between partners. While not a cure for HIV, such a medicine may help reduce the spread of this disease, which would be a vital step toward its eradication.
Sorry, comments are not allowed for this post.
- Art and Culture (3)
- Attitude and Behavior (9)
- Chemistry (9)
- Computer and Digital Technology (7)
- Earth Science (6)
- Education and Policy (4)
- Energy (5)
- Engineering (8)
- Environment and Sustainability (9)
- Health and Medicine (17)
- Manufacturing and Industry (7)
- Math (2)
- Museums (2)
- Physics (8)
- Space and Astronomy (16)
- Technology (18)
- Transportation (3)
- Happening Now
Take a visually stunning journey into the future of NASA space exploration.
Explore the history and future of materials that impact our lives everyday.
- Coming Soon
Write the team behind the blog with your questions or comments.